R
Recursion Pharmaceuticals
RXRX · NASDAQ · Healthcare
$3.22
+$0.04 (+1.26%) today
Loading live data...
Market Cap
$1.72B
24h Volume
$29.8M
P/E Ratio
-4.3
52w High
$6.79
52w Low
$2.84
Est. AI Revenue
85%
Loading chart data...
7-Day Sparkline (Static)
About Recursion Pharmaceuticals
Clinical-stage TechBio company using AI and massive biological datasets to decode biology and industrialize drug discovery.
CEO: Chris Gibson
Founded: 2013
HQ: Salt Lake City, Utah
Employees: 600
Performance
24 Hours+1.26%
7 Days+7.33%
30 Days-14.36%
1 Year-39.93%